|
.GIF) 
ANDA Abbreviated New Drug Applications
Vesta Pharmaceuticals has on-staff industry experts in the field of Abbreviated
New Drug Applications (ANDA). ANDA is the FDA’s expedited process to approve
the generic pharmaceuticals that compete with innovator drugs coming off patent
protection. ANDA eliminates the need for costly clinical trials as long as the
generic drug is scientifically proven as bioequivalent to the original drug.
Vesta Pharmaceuticals has experienced, dedicated experts devoted to guiding you
every step of the way through the ANDA process.
Consumers and governments alike are pressuring the
pharmaceutical industry to produce more high quality, effective prescription
medications at significantly reduced prices; therefore, demand for generic
prescriptions will continue to skyrocket. Vesta Pharmaceuticals is
positioned perfectly to partner with your company to develop, manufacture, and
deliver the high-quality generic drugs you need to propel your business’ growth.
Vesta will manufacture your generic drugs in our FDA-registered facility with
the utmost consistency and quality, and we will deliver your product exactly
when you need it.
CLICK HERE: To
View Our VESTA® Brochure
Home |
Who We Are |
Dietary Contract Manufacturing |
Industrial Use Products |
Research & Development
International Distribution Partner Program |
Career Opportunities |
Contact Us
Copyright © 2008 - Vesta Pharmaceuticals, Inc. - All rights reserved.
|